EW vs. GEHC: Edwards Lifesciences vs. GE HealthCare Stock Comparison

Company Profile

Edwards Lifesciences (EW) and GE HealthCare (GEHC) are both classified in the Health Care Equipment sub-industry within the broader Health Care Equipment & Supplies industry, placing them in the closest GICS peer bucket.

Edwards Lifesciences (EW) has more than two decades of public-market history since March 27, 2000, whereas GE HealthCare (GEHC) listed on December 15, 2022 and has a much shorter record to draw on.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

GE HealthCare (GEHC) at 20.01% sits in the top ROE quartile, while Edwards Lifesciences (EW) at 9.33% is closer to the peer norm — stronger capital efficiency for GEHC.

For every dollar of sales, both Edwards Lifesciences (EW) at 15.30% and GE HealthCare (GEHC) at 9.95% retain more as net profit than most peers, landing in the top net margin quartile of their industries.

Both Edwards Lifesciences (EW) at 30.15% and GE HealthCare (GEHC) at 15.33% convert sales into operating profit at a top-quartile rate, pointing to tighter cost discipline before financing and tax.

Profitability Metrics

Growth

Both Edwards Lifesciences (EW) at 11.55% and GE HealthCare (GEHC) at 4.84% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.

GE HealthCare (GEHC) at 4.84% is around its peer norm for EPS growth, while Edwards Lifesciences (EW) at -73.74% drops into the bottom quartile, signaling weaker earnings momentum.

Growth Metrics

Financial Strength

Edwards Lifesciences (EW) at 4.60 carries current ratio above its industry’s typical mid-range, while GE HealthCare (GEHC) at 1.30 runs in the tighter-liquidity quartile — different working-capital profiles, both worth examining.

Edwards Lifesciences (EW) at 0.06 keeps leverage in the lower industry quartile, while GE HealthCare (GEHC) at 0.88 runs a more typical debt-to-equity mix.

Financial Strength Metrics

Dividends

Edwards Lifesciences (EW) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile GE HealthCare (GEHC) reports a yield of 0.17%, ranking against industry peers normally.

Edwards Lifesciences (EW) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile GE HealthCare (GEHC) reports a payout of 2.96%, ranking against industry peers normally.

Dividend Metrics

Valuation

GE HealthCare (GEHC) at 17.42 sits in the cheaper P/E ratio quartile, while Edwards Lifesciences (EW) at 59.38 sits in the richer quartile — a clear split in what investors pay for each dollar of trailing earnings.

GE HealthCare (GEHC) at 1.72 is priced about in line with its industry on P/S ratio, while Edwards Lifesciences (EW) at 8.80 sits in the pricier quartile — EW costs more per dollar of sales.

On P/B ratio, both Edwards Lifesciences (EW) at 5.41 and GE HealthCare (GEHC) at 3.21 are valued close to their industries’ norm against book — neither stands out from peers.

Valuation Metrics